at teva, the acting chief go back tos going to being chief finance officer of teva.allenges facing vigodman. a six year low, we have got the potential for generic competition for its $4 billion blockbuster multiple sclerosis treatment as early as this year. he needs to regain confidence of investors, real challenges facing him. they have he's amounts of debt -- they have huge amounts of debt. yesterday trying to make a bid for a u.s. company around $150 million, that company has treatments for migraines. >> elliott gotkine from tel aviv. talk abouthave to novartis later, it is also doing a share swap with merck. we will cover that. rolls-royce talked sales record for the fourth straight year in 2013. >> ryan chilcote spoke to the ceo and joins us now with more. pedal to the metal. >> this is one of the reasons why they had that record year, this is rolls-royce's first t ever.r, coupe, you just press the button, pretty straightforward. the whole idea of this car -- make sure we don't roll into anybody. open up a new market, pretty successfully. going after younger peo

elliott, at least you have some >> news for teva.e, if it's not bad news i guess it must be good news. certainly, people hope this will bring a bit of stability to teva. let's not forget a few months ago jeremy 11 parted company with teva following a spat with the board over a restructuring plan. and very well-known business circles. he is already a board member of former member of the strauss group. he is the still the chief executive of the world's largest agrochemicals maker. very well-known known in the business community in israel. respected as well. vicki will be for him to translate that over to the united states whereteva is listed in where most of its shareholders reside, francine. ?> challenges >> is going to have a series of challenges. blockbuster multiple sclerosis treatment brings in $4 billion per year. that is due to face generic competition as early as this year. if it faces generic composition -- generic competition, and how many of them do so, it will depend on the dent that teva's earnings take. the second is rega

taylor -- teva may name a new ceo this month. this be a turnaround for the struggling drugmaker? we have more next. ♪ >> welcome back to "on the move ." i am francine lacqua here in london. here are some companies on the move. htc's posted net income that missed estimates for a fourth straight quarter. rising competition from chinese brands led to a decline in sales. the release of its new phone failed to stop a slide in sales for nine quarters. surged 49% inales 2013. ford overtook for you as the fifth-largest foreign automaker. the popularity of the focus helped sales expand faster than any major competitor. amazon's jeff bezos was airlifted from the galapagos islands on new year's day. up by ancked ecuadorian navy helicopter due to kidney stones. teva could have a new ceo as early as this month. two people close to the matter of anez vigodman, the ceo israeli chemicals maker will take over. our middle east editor elliott gotkine has more from tel aviv. at last, some encouraging news from teva. news, i is not bad suppose it mus

teva has named a new ceo. he will succeed jeremy 11 who left following a spat with the board. gotkine has more from tel aviv. vigodman would take over next month. >> yes, february 11 is when he is due to take up the role. he is currently a board member anyway. he is also chief executive of the world's largest agrochemicals maker. andurned the company around the board of teva hoping that he will be able to repeat the same trick at the world's largest manufacturer of generic drugs. at the same time in terms of positions at teva, you have had -- or, acting ceo who will go back to being chief finance officer. vigodman has a lot of challenges to deal with. share prices hovering around a six-year low. their blockbuster drug things in $4 billion worth of sales each year. it could face generic competition as early as this year. a lot for him to get a grip on. a naming that is we were expecting. republic -- we reported on the select couple of days and it has been confirmed. >> teva is a big player in the generics market. you also have your eye on another drug marker, novartis. >> we ha

mack more and ryan lewis, madonna and queen la teva ta at that joined the duo to perform their song, same love. >> to celebrate same love and have the marriages on stage, my sister getting married as well was phenomenal. >> reporter: beyonce and jay z rocked the show's opening with their duet. jay z had a message for his baby girl. >> i want to tell blue that look, daddy got a gold cup for you. >> reporter: paul mccartney and ringo starr reunited just before the beatles 50's anniversary. >>> coming up in the next half hour, betty was at the grammys and gives us an in-depth look at what it took to put that surprise wedding together. >>> coming up at 6:09. big grammy surprise filled with love. what it took to pull off that mass wedding at the grammys. >>> plus a prayer for peace becomes anything but peaceful. the real life angry bird that disrupted the pope's ceremony. >>> rain back in the area forecast. the day you should expect it still, straight ahead. >>> a slow monday commute at the bay bridge toll plaza. delays extending to the east parking lot and the metering lights are on. mor

as he said, francine, he is a teva.t of has the trust of the investor community and israel and the trick is to translate that to the united states. have a new man but the same problems, basically. >> guy, my chemistry teacher used to say same woman different hat or just because you have a different face there in the form doesn't chief executive mean the problems will go away. the multibillion- dollar multiple sclerosis drug. much you can do about that. it could make it huge dent in the revenues and profits of teva. that itself is a reason the company is downsizing a little inflate 10% of its workforce. they haven't exactly been doing wonderfully over the last two years. they are hovering around a six- year low. they're up a little bit today, but overall they have been at a six-year low. the confidence of investors. get off to could reasonably good start. he has the backing of an activist investor who had written a letter to other investors encouraging them to support the goodman role as chief executive. there was a lett

information and hacking the north korean regime south korean police called to the similar event last of teva up to the north promised to wipe out the perfect as with most inspiring north and south koreas remain technically at war following the korean war which ended in nineteen fifty three israel's defense minister mostly i want to strike a rear condemnation from washington statements he made criticizing us secretary of state john kerry what the israeli defense had termed obsessive and miss ionic attempts to bring about an israeli palestinian peace deal. the us state department called the comments offensive and inappropriate. israeli prime minister benjamin netanyahu scrambled to defuse the situation explaining that the two countries were working together to promote peace and that any disagreements with the us administration were not personally know god has opened the door. even when we have disagreements with the united states. they always contain the natural and and on all personal history of cooperating with the united states president the vice president to visit again. and with the secre

. >> teva pharmaceuticals likely to name a board member.usted october after a conflict with the board. >> ebay shares falling after downgraded them to equal weight. slashing its price target by a dollar. analysts favor things like amazon over ebay. agreeing to acquire spectrum from verizon for about $2.4 billion in cash as part of an airwaves swap that would give both companies more network capacity. t-mobile expects the deal to close in the middle of the year. >> intel set to debut some of its mobile technology and wearable technology at the consumer electronics show today according to a person with knowledge of the plan. the new products, as intel looks to stay relevant amid tc decline. sachsst solar, goldman downgrading them due to a lack of earnings. a shift to rooftop solar will hurt them. goldman lowering the price target to $45 from $62. to underweight from equal weight at morgan stanley with a price target of 33 dollars a steal. it rallied 50% over the past month, organ stanley says twitter trade at a premium to its peers and the ba

. >> do you prefer some of the health-care stocks to a teva hermeneutical's?he health-care stocks and biotech stocks. amgen, gilliard. >> and they are some of the best performers. >> it is getting expensive, but given the kind of work they are doing, i am very positive on those stocks. >> how much does it have to do with the pipeline and how much does it have to do with mna quest -- with m&a? both,is a combination of but it is more of a pipeline story. >> if we look traditionally, when stocks go up, m&a closely follows. there was not this correlation because markets were pumped. >> if you believe that the economic growth has caught up and you give incentive to ceo's to make acquisitions, it all comes down to positivity in the market and sentiment. >> anything in currencies? >> i like the dollar. the euro-dollar, the ecb weakened its forward guidance and we had a dad jobs report on friday and the euro rallied. it might be that the euro-dollar will stay in the range of 1.36, 1.34. i do not see a huge downside. if anything, i see downside to the euro and not the

san i bell and cap teva islands ranked second. and mccallan, texas third-best.s. ght? ♪ like, really big... then expanded? ♪ or their new product tanked? ♪ or not? what if they embrace new technology instead? ♪ imagine a company's future with the future of trading. company profile. a research tool on thinkorswim. from td ameritrade. but he's got such sensitive skin that you worry about what you use in the laundry. my tide, downy, and bounce all come in free & gentle. so we get a cleaner, softer blankie. [ gasps ] [ female announcer ] tide, downy, and bounce free & gentle. suddenly you're a mouth breather. a mouth breather! how do you sleep like that? you dry up, your cold feels even worse. well, put on a breathe right strip and shut your mouth. cold medicines open your nose over time, but add a breathe right strip, and pow! it instantly opens your nose up to 38% more so you can breathe and do the one thing you want to do. sleep. add breathe right to your cold medicine. shut your mouth and sleep right. breathe right. at a company that's bringing media and technol